Search results :

Testosterone

More information: STITCH, PubChem (stereo-specific compound: 1) and possibly Wikipedia

ATC Code: G03BA03

Side effects

Options: Show MedDRA Preferred Terms,   display all 34 labels

Side effect Data for drug Placebo Labels
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20
Application site pruritus 17% - 37%
Blister uncommon — 3% - 12% x x
Burn 12% x
Prostatomegaly postmarketing, 11.7% x x x x
Mouth irritation 9.2% x
Application site irritation 0.5% - 8% 0% x
Back pain 6% x
Laboratory test abnormal postmarketing, 3% - 9.3% x x x x x
Application site vesicles postmarketing, 6% x x
Injection site pain postmarketing, 4.58% - 4.6% x x x
Taste bitter 4.1% x
Application site reaction postmarketing, 0.5% - 16.1% x x x x x x x x
Allergic contact dermatitis common, 4% x x
Haematocrit increased postmarketing, 0.7% - 7% x x x
Application site erythema postmarketing, 1.2% - 7% 2% x x
Diarrhoea postmarketing, 3% - 4% x x x x x
Prostatic disorder 3% - 5% x x x x
Vomiting postmarketing, 3% - 4% x x x x
Induration common, 3% x x
Acne postmarketing — 0.5% - 8% x x x x x x x x
Application site burn postmarketing — 3% x x x
Prostatic specific antigen increased postmarketing, 1% - 11.1% 0% x x x x x
Hypogonadism 2.6% - 2.61% x
Oestradiol increased 2.6% - 2.61% x
Anaemia postmarketing, 2.47% - 2.5% x x x x
Dermatitis contact 2.14% - 4% 0% x
Dysgeusia postmarketing, 2% x x
Gastrointestinal haemorrhage postmarketing — 2% x x x
Gingival swelling postmarketing, 2% x
Gingival oedema 2% x
Haemoglobin increased postmarketing, 0.2% - 4.6% 0% x x x x x x x
Pruritus postmarketing — 1.85% - 39% x x x x x x x x x x x
Testicular disorder postmarketing, 0% - 3% x x x x x
Dry skin postmarketing, 1.85% - 1.9% x x x x
Application site induration postmarketing, 3% x x
Ejaculation disorder 1.31% x
Injection site erythema 1.31% x
Hypertension worsened 0.2% - 1.3%
Red blood cell count increased 0.2% - 1.3%
Prostate carcinoma postmarketing — 1.2% - 1.23% x x x x x
Application site rash postmarketing, 0.5% - 1.8% x x
Depression postmarketing, 0% - 3% x x x x x x
Gynaecomastia postmarketing, 0% - 3% 0% x x x x x x x x x x x x x x x
Headache postmarketing, 0% - 6% 0% x x x x x x x x x x x x x x x x x
Breast pain postmarketing, 1% - 3% x x x x x x x x x
Taste disorders 1% 0% x x
Mood swings postmarketing, 0% - 3% 0% x x x x x x x x x x
Blood pressure increased postmarketing, 1% 0% x x x x
Prostate induration postmarketing, 1.31% x
Benign prostatic hyperplasia postmarketing, 0% - 1.3% 1% x x
Pain uncommon x x x x x
Pelvic pain uncommon x x
Urinary tract infection uncommon x x x x
Vertigo uncommon x x
Peripheral vascular disorder uncommon x x
Lacrimation increased 0% - 1% 0% x
Blood pressure diastolic decreased 0% - 1% 0%
Spontaneous penile erection 0% - 1% 0% x x
Confusional state postmarketing, uncommon x x x
Urinary incontinence postmarketing, uncommon x x x
Growth accelerated postmarketing, uncommon x x x
Increased appetite postmarketing, uncommon x x x x x x
Abdominal pain postmarketing x x x
Aggression postmarketing, 1.31% x x x x x x x x x
Alopecia postmarketing, 0% - 1% x x x x x x x x x x x
Amnesia postmarketing x x x x x
Anaphylactic shock postmarketing x
Anger postmarketing x x x
Angina pectoris postmarketing x
Angioedema postmarketing x
Anxiety postmarketing, uncommon x x x x x x x x x x x x x x x
Arthralgia postmarketing x x x
Asthenia postmarketing, 0% - 3% x x x x x x x
Asthma postmarketing x x
Mental disorder postmarketing x x x x x x x x
Breast disorder postmarketing x x x x x x x x x
Cerebral infarction postmarketing x
Transient ischaemic attack postmarketing x x
Chest pain postmarketing x
Infection postmarketing x x x x
Connective tissue disorder postmarketing x x x x x x
Cough postmarketing x
Cyst postmarketing x x x x
Sudden hearing loss postmarketing x
Libido decreased postmarketing — 0% - 3% x x x x x x x x x x x x x
Dermatitis atopic postmarketing x x
Diabetes mellitus postmarketing x
Dizziness postmarketing x x x x x x x x
Dyspnoea postmarketing x x x x x x x
Dysuria postmarketing, uncommon x x x x
Oedema postmarketing x x x x x
Endocrine disorder postmarketing x x x x x x
Epididymitis postmarketing
Rash postmarketing — 2% x x x x x x x x
Eye disorder postmarketing x x
Fatigue postmarketing — 1.96% x x x x x x
Gastrointestinal disorder postmarketing x x x x x x x x x x
Cardiac arrest postmarketing x
Cardiac disorder postmarketing x x
Cardiac failure postmarketing x
Haematuria postmarketing, uncommon x x x x
Hirsutism postmarketing x x x x x x x x x x x x
Hostility postmarketing x x x x x
Hypercholesterolaemia postmarketing x x
Hyperhidrosis postmarketing, 1.31% x
Hyperlipidaemia postmarketing x x x x x x
Hyperparathyroidism postmarketing x
Hypersensitivity postmarketing x x x x x x
Hypertension postmarketing — 0% - 3% 0% x x x x x x x x x x x x x
Hypertriglyceridaemia postmarketing x x x x x
Hyperventilation postmarketing x
Hypoglycaemia postmarketing x
Hypokalaemia postmarketing x x x
Immune system disorder postmarketing x x x x
Incontinence postmarketing x x
Libido increased postmarketing x x x x x x
Irritability postmarketing, 1.96% x x x
Hepatic neoplasm postmarketing x x
Chronic obstructive pulmonary disease postmarketing x
Systemic lupus erythematosus postmarketing x
Mediastinal disorder postmarketing x x x x
Musculoskeletal pain postmarketing x
Myocardial infarction postmarketing x
Nausea postmarketing x x x x x x x x x x x x x x
Neoplasm postmarketing x x x x x
Nervous system disorder postmarketing x x x x x x
Nervousness postmarketing, 0% - 3% x x x x x x x
Nocturia postmarketing x
Oligospermia postmarketing x x x x x x x x x x x x
Osteopenia postmarketing x
Osteoporosis postmarketing x
Pain in extremity postmarketing x
Paraesthesia postmarketing, uncommon x x x x x x x x
Peliosis hepatis postmarketing x x x x x x x
Personality disorder postmarketing x x
Polycythaemia postmarketing x x x x x x x x x x x x x x
Polyp postmarketing x x x x
Priapism postmarketing x x x x x x x
Prostatitis postmarketing x
Male orgasmic disorder postmarketing x
Precocious puberty postmarketing x x x
Pulmonary embolism postmarketing x
Rhinitis postmarketing x
Seborrhoeic dermatitis postmarketing x x x x x
Shock postmarketing x
Sleep apnoea syndrome postmarketing x x x x x x
Snoring postmarketing x
Spermatocele postmarketing x
Stomatitis postmarketing x
Cerebrovascular accident postmarketing x
Sweating postmarketing x x x x x
Swelling postmarketing x
Syncope postmarketing x
Tachycardia postmarketing x x
Testicular pain postmarketing x
Thrombocytopenia postmarketing x
Thromboembolism postmarketing x
Thrombosis postmarketing x
Tinnitus postmarketing x
Erythema postmarketing — 8% x x x x x x x
Pollakiuria postmarketing x x
Urinary tract disorder postmarketing x x
Urticaria postmarketing x x
Varicocele postmarketing x
Angiopathy postmarketing x x x x x x x x x x x x
Vasodilation postmarketing x x x x x
Venous insufficiency postmarketing x
Virilism postmarketing x x x x x x x x
Vitreous detachment postmarketing x
Weight increased postmarketing, 1.31% x x x x x x x
Dry mouth postmarketing x x
Urinary retention postmarketing x
Urogenital disorder postmarketing x x x x
Micturition urgency postmarketing x
Agitation postmarketing x x
Oedema peripheral postmarketing x x x x x x
Mouth ulceration postmarketing
Deep vein thrombosis postmarketing x x x x
Migraine postmarketing x x
Injection site abscess postmarketing x
Gamma-glutamyltransferase increased postmarketing x x x
Hair discoloration postmarketing x x x x x
High density lipoprotein decreased postmarketing x x x x
Injection site reaction postmarketing x
Liver function test abnormal postmarketing x x x x x x x x
Coronary artery occlusion postmarketing x
Vesiculobullous rash postmarketing x x
Aspartate aminotransferase increased postmarketing x x x
Alanine aminotransferase increased postmarketing x x x
Urinary hesitation postmarketing x
Renal colic postmarketing x
Testicular atrophy postmarketing x x x x
Enlarged clitoris postmarketing x x x x x x x x x
Androgenetic alopecia postmarketing x x x x x
Malnutrition postmarketing x x x x x
Unspecified disorder of skin and subcutaneous tissue postmarketing x x x x x x x x x
Malaise postmarketing x x x x x x x
Myalgia postmarketing x x x x
Abdominal pain upper postmarketing x
Tenderness postmarketing
Intraocular pressure increased postmarketing x
Pharyngeal oedema postmarketing x
Lip swelling postmarketing
Prostate infection postmarketing x
Testosterone low postmarketing x x
Cerebrovascular insufficiency postmarketing x
Erectile dysfunction postmarketing, uncommon x x x x x
Hepatobiliary disease postmarketing x x x x x x
Fluid retention postmarketing x x
Korsakoff's psychosis (non-alcoholic) postmarketing x
Breast induration postmarketing x
Glucose tolerance impaired postmarketing x x x x x
Prostatic intraepithelial neoplasia postmarketing x
Blood bilirubin increased postmarketing x x
Atrophy postmarketing
Cognitive impairment postmarketing x x
Prostate cancer postmarketing, 1.31% x x x x x x x
Nephrolithiasis postmarketing x
Transaminases increased postmarketing x
Poor urinary stream postmarketing x
Respiratory distress postmarketing x
Musculoskeletal chest pain postmarketing x
Pulmonary microemboli postmarketing x
Injection site irritation postmarketing x
Influenza like illness postmarketing x
Injection site haematoma postmarketing x
Surgical intervention postmarketing x x x x x x
Renal pain postmarketing x
Blood glucose increased postmarketing x x
Hot flush postmarketing, 0% - 1% 0% x x x x x x
Erythropoiesis abnormal postmarketing x x
Abdominal symptom postmarketing x
Infestation NOS postmarketing x x
Blood and lymphatic system disorders postmarketing x x x x x
Ear and labyrinth disorders postmarketing x
Administration site reaction postmarketing x x
Sleep disorder postmarketing x
Blood testosterone decreased postmarketing x
Blood testosterone increased postmarketing x
Blood triglycerides increased postmarketing x x
Blood prolactin increased postmarketing x
Serum testosterone decreased postmarketing x
Pharyngolaryngeal pain postmarketing x
Insomnia postmarketing, 0% - 1.96% 0% x x x x x x x x x
Injection site discomfort postmarketing x
Free prostate-specific antigen increased postmarketing x x
Prostate examination abnormal postmarketing x
Rash papular postmarketing x
Dysphonia postmarketing x
Procedural pain postmarketing x
Venous thromboembolism postmarketing x x x x x x
Coronary artery disease postmarketing x
Pulmonary oil microembolism postmarketing x
Leukocytoclastic vasculitis postmarketing x
Abdominal cramps x
Amenorrhoea x x
Appetite disorder
Arthritis x
Benign prostatic hypertrophy x
Clotting x x x x x
Breast cyst x
Bronchitis x
Carcinoma x
Contusion x x
Diplopia x
Eczema x
Folliculitis x
Gastrooesophageal reflux disease
Gingival recession
Gingivitis x
Haemarthrosis
Haemorrhage x x x x x x
Hyperaesthesia x
Inflammation x x x x x
Jaundice cholestatic x x x x x
Leukoplakia x
Nasal congestion x
Nasopharyngitis x x
Palpitations x
Penis disorder x x x x
Pneumonia
Polyuria
Neoplasm prostate x
Pruritus genital x
Renal failure x x x
Rosacea x
Serum sickness x
Sinusitis x x x
Skin disorder
Toothache x
Ulcer x x x
Upper respiratory tract infection x
Chills
Hepatic function abnormal x
Oral lesion x
Paresthesia generalized x x x x
Creatinine increased x x
Generalised oedema x
Epiphyses premature fusion x
Kidney function abnormal x
Prothrombin level increased x x
Hypogeusia x
Skin irritation x
Menstruation irregular x x
Depression suicidal x x
Urination impaired x
Chest tightness x
Hair growth abnormal
Disturbance in attention x
Affect lability x
Clitoral engorgement x
Abnormal dreams x
Dermatitis acneiform
Application site oedema x
Eye redness x
Buccal inflammation x
Blood creatinine increased x x
Chest discomfort x
Throat tightness x
Gingival pain x
Nipple pain
Activated partial thromboplastin time prolonged x x
Vaginal burning sensation x
Strangury x
Breast tenderness x
Soft tissue disorder
Lip ulceration
Blood pressure systolic increased
Anaphylactoid reaction x x x x x
Haemoglobin abnormal
Nipple disorder
Lacrimation
Hyperkinesia x x x x
Blood urea normal
Nasal oedema x
Penile pain
Prostatic adenoma x x
Paraesthesia oral x
Affective disorder
Bad taste x
Detachment psychological
Lipids abnormal x
Balance disorder x
Cholesterol serum elevated x x x
Stinging x
Sweating increased x
Bilirubin total increased x x
International normalised ratio increased
Buccal mucosal roughening x
Raised serum lipid levels x
Application site warmth x
Application site dryness
Abnormal clotting factor x
Redness gum x
Irritation gum x
Gingival blister x
Impatience
Gastrointestinal hypomotility x
Epidermal necrosis x x
Sensitisation x x
Parosmia
Application site exfoliation
Breast enlargement x
Hepatocellular carcinoma x
Prostatic dysplasia x

Indications

Information about indications was extracted from the indications and usage sections of the labels.

TESTOSTERONE

Side effects:17
Source:FDA Structured Product Label

TESTOSTERONE

Side effects:18
Source:FDA Structured Product Label

TESTOSTERONE

Side effects:19
Source:FDA Structured Product Label

Testosterone

Side effects:22
Source:FDA Structured Product Label

Testosterone

Side effects:22
Source:FDA Structured Product Label

TESTOSTERONE

Side effects:22
Source:FDA Structured Product Label

TESTOSTERONE

Side effects:23
Source:FDA Structured Product Label

TESTOSTERONE

Side effects:24
Source:FDA Structured Product Label

Testosterone implants or 200mg / Testosterone Implants

Side effects:35
Source:medicines.org.au

Testosterone / Androderm, Transdermal patch

Side effects:35
Source:Medsafe

TESTOSTERONE / ANDROGEL

Side effects:38
Source:FDA

TESTOSTERONE

Side effects:39
Source:FDA Structured Product Label

testosterone

Side effects:40
Source:FDA Structured Product Label

testosterone / testosterone

Side effects:63
Source:EMA

testosterone

Side effects:65
Source:FDA Structured Product Label

testosterone

Side effects:73
Source:FDA Structured Product Label

testosterone

Side effects:74
Source:FDA Structured Product Label

TESTOSTERONE / ANDRODERM

Side effects:92
Source:Health Canada

TESTOSTERONE / ANDROGEL -(5G/PACKET)

Side effects:117
Source:Health Canada

TESTOSTERONE

Side effects:157
Source:FDA Structured Product Label

Color scheme:

standard – alternative

    100%
    75%
    50%
    10%
    frequent (1% to 100%)
    infrequent (0.1% to 1%)
    rare (<0.1%)
    postmarketing
    0%
    no frequency information
    not found on label